Ashley Geller is a Portland, Maine based nurse practitioner. Active license number of Ashley Geller is CNP181239 for Acute Care in Maine. Her current practice location is 22 Bramhall St, Scu 3, Portland. Patients can reach her at 207-662-0111. Ashley Geller is NP and her NPI number (Unique professional ID assigned by NPPES) is 1588928212. Ashley Geller has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Ashley Geller speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1588928212
NPI Enumeration Date:
27 Jun, 2012
NPI Last Update On:
03 Oct, 2018
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ashley Geller are as mentioned below.
License Number
Specialization
State
Status
CNP181239
Acute Care
Maine
Primary
SP013785
Nurse Practitioner
Pennsylvania
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Ashley Geller 22 Bramhall St, Scu 3 Portland, Maine
Zip:
04102-3175
Phone Number:
207-662-0111
Patients can reach Ashley Geller at 22 Bramhall St, Scu 3, Portland, Maine or can call to book an appointment on 207-662-0111.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.